Sepracor/Aventis Agreement Would Aid Estorra Filings Outside The U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
Under the tentative deal, Sepracor would be allowed to reference Amoban regulatory filings in Estorra marketing applications outside the U.S. The agreement is conditional on the successful completion of the Aventis/Sanofi merger.